These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34145099)

  • 41. Management of relapsed gestational trophoblastic neoplasia: What can help to reduce the re-recurrence rate?
    Wang X; Cheng Y; Li W; Mao R; Zhu T; Lu J; Yue X; Lu X
    J Obstet Gynaecol Res; 2022 Jun; 48(6):1451-1457. PubMed ID: 35289459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study.
    Freitas F; Braga A; Viggiano M; Velarde LGC; Maesta I; Uberti E; Madi JM; Yela D; Fernandes K; Silveira E; Leal E; Sun SY; Dos Santos Esteves APV; Filho JR; Junior JA; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2020 Aug; 158(2):452-459. PubMed ID: 32402634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of efficacy and safety of chemotherapy in the treatment of recurrent or resistant gestational trophoblastic neoplasia: A protocol for systematic review and meta-analysis.
    Luo F; Li L; Gao Q; Li YX
    Medicine (Baltimore); 2021 Oct; 100(40):e27320. PubMed ID: 34622830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN).
    Cho HW; Ouh YT; Min KJ; Lee NW; Lee S; Song JY; Hong JH; Lee JK
    Gynecol Oncol; 2020 Mar; 156(3):606-610. PubMed ID: 31954533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Application of chest CT scan in gestational trophoblastic neoplasia with lung metastasis].
    Cheng Y; Ma FH; Wang XR; Le XN; Zhang GF; Lu X
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):384-389. PubMed ID: 29961280
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD008891. PubMed ID: 26760424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008891. PubMed ID: 23235667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid.
    Taylor F; Grew T; Everard J; Ellis L; Winter MC; Tidy J; Hancock BW; Coleman RE
    Eur J Cancer; 2013 Oct; 49(15):3184-90. PubMed ID: 23870384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of low-risk gestational trophoblastic neoplasia.
    Winter MC
    Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():67-80. PubMed ID: 33741258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gestational trophoblastic neoplasia in adolescents.
    Rauh-Hain JA; Growdon WB; Braga A; Goldstein DP; Berkowitz RS
    J Reprod Med; 2012; 57(5-6):237-42. PubMed ID: 22696819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.
    Feng F; Xiang Y; Wan X; Geng S; Wang T
    Ann Oncol; 2011 Jul; 22(7):1588-1594. PubMed ID: 21239399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-Risk Gestational Trophoblastic Neoplasia in Manitoba: Experience With Alternating Methotrexate and Dactinomycin.
    Carlson V; Walters L; Lambert P; Dean E; Lotocki R; Altman AD
    Int J Gynecol Cancer; 2018 Oct; 28(8):1448-1452. PubMed ID: 30095710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.
    Chapman-Davis E; Hoekstra AV; Rademaker AW; Schink JC; Lurain JR
    Gynecol Oncol; 2012 Jun; 125(3):572-5. PubMed ID: 22449733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 10-Year Clinical Experience of Gestational Trophoblastic Disease at Rajavithi Hospital, 2001-2010.
    Yanaranop M; Potikul C; Tuipae S
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S17-27. PubMed ID: 27266212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
    Lybol C; Sweep FC; Harvey R; Mitchell H; Short D; Thomas CM; Ottevanger PB; Savage PM; Massuger LF; Seckl MJ
    Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of 5-day MTX and 5-day ETP treatment results and early predictors of drug resistance to 5-day MTX in patients with post-molar low-risk gestational trophoblastic neoplasia.
    Kizaki S; Hashimoto K; Matsui H; Usui H; Shozu M
    Gynecol Oncol; 2015 Dec; 139(3):429-32. PubMed ID: 26456138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?
    Essel KG; Bruegl A; Gershenson DM; Ramondetta LM; Naumann RW; Brown J
    Gynecol Oncol; 2017 Jul; 146(1):74-80. PubMed ID: 28473205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of immune checkpoint inhibitors combined with chemotherapy in recurrent drug-resistant gestational trophoblastic neoplasia: Four case reports and literature review.
    Liu W; Zhu Y; Wang Y; Li R; Zou D; Chen R; Yang L; Huang Y
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2016. PubMed ID: 38425251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
    Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS
    Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.